Cardinal Health's fiscal fourth-quarter results, released this morning, contain a line item that is bigger than the company it appears in: "recognition of a one-time net operating profit impact of IEEPA tariff refunds of $100 million in the GMPD segment" [1]. Money paid under the tariffs the Supreme Court struck down is now flowing back, and for the first time it is flowing back in a form you can put on a chart.
Start with what the $100 million did to the quarter, because the release publishes both versions of the number. Reported fourth-quarter non-GAAP earnings were $2.91 per share, up 40 percent from a year ago. Excluding the refund, the same quarter earned $2.60, up 25 percent [1]. The difference is 31 cents a share and 15 points of growth rate. The full-year figures move by the same 31 cents, $11.26 reported against $10.95 excluding the item, which tells you the entire refund was recognized in the fourth quarter [1].
The refund is simultaneously large and small, and the frame matters. Against Cardinal Health's scale, it rounds away: revenue was $63.7 billion for the quarter, up 6 percent, and $254.2 billion for the fiscal year, up 14 percent, with fiscal 2027 guidance of $12.40 to $12.60 in EPS, growth of 13 to 15 percent [1]. The company excludes the item from its own growth story precisely because it will not repeat. What does not round away is what the line item represents: a documented instance of tariff money moving in reverse, from the government back to a company that paid it, in an amount the company was required to disclose.
The legal history that produced the line is short. The tariffs were imposed under the International Emergency Economic Powers Act; the Supreme Court struck them down; refunds of duties collected under them are the mechanical consequence. What the release does not say is also worth recording: it does not specify which entity pays the refund, on what schedule, or whether more is coming in later periods [1]. The disclosure establishes that refunds are real and material, not how the pipeline works.
The policy, meanwhile, has not stayed struck down so much as changed statutes. On July 23 the administration announced a replacement round of tariffs on the European Union and 59 other countries, citing Section 301 of the Trade Act, and on August 3 a coalition of 25 states sued, arguing the administration skipped the investigations the statute requires [2]. The states' release walks the same history the Cardinal line item does, noting the Supreme Court struck the IEEPA tariffs and the Court of International Trade struck a Section 122 round [2]. New York Attorney General Letitia James, announcing the suit: "After losing at the Supreme Court, the administration is once again trying to illegally raise taxes on families and businesses with a new round of tariffs." [2]
One company's $100 million is one company's $100 million, and it would be a mistake to multiply it into an economy-wide figure; this desk will not, because no public accounting yet exists of total IEEPA duties refunded or owed. The only countable unit right now is the line item, and the place line items surface is earnings season. Cardinal Health's disclosure is the template: a one-time gain, segregated from operating results, sized to the duties the company paid. Each one that prints is a receipt for a tax that a court found unlawful after it had already been collected, arriving back on the ledger of the company that advanced it, while the households that paid it at retail wait on no refund at all.
